65. Primary immunodeficiency Clinical trials / Disease details


Clinical trials : 500 Drugs : 614 - (DrugBank : 119) / Drug target genes : 92 - Drug target pathways : 217

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00001145
(ClinicalTrials.gov)
October 19993/11/1999Study of Immune Responses and Safety of Recombinant Human CD40 Ligand in Patients With X-Linked Hyper-IgM SyndromeStudy of Immune Responses and Safety of Recombinant CD40 Ligand in Patients With X-Linked Hyper IgM SyndromeImmunoproliferative DisorderDrug: Bacteriophage;Drug: rhuCD40L;Drug: KLHNational Institute of Allergy and Infectious Diseases (NIAID)NULLCompletedN/AN/ABoth5Phase 2United States